
Matthew Campbell
Articles
-
Jul 5, 2024 |
onlinelibrary.wiley.com | Ensieh Habibi |Michael Miller |Andrea D. Schreier |Matthew Campbell
1 INTRODUCTION Adaptation drives populations towards phenotypes that best fit a present environment (Fisher 1930). Of particular interest is rapid adaptation that occurs with artificial propagation and maintenance of organisms for conservation purposes.
-
Jul 2, 2024 |
biorxiv.org | Matthew Campbell |Joy A. Becker
AbstractContextLates calcarifer known as barramundi perch, is widespread in the tropical Indo-Pacific region and is an important taxon in aquaculture, recreational and commercial fisheries. With mitochondrial barcoding study of barramundi perch, three clear mitochondrial clusters have emerged. AimsTo test for congruent signal between mitochondrial and nuclear genomes and to test for population genetic structure.
-
Nov 2, 2023 |
mdpi.com | Matthew Campbell |Tian Zhang
1. IntroductionIn the past two decades, therapy development in the treatment of renal cell carcinoma has exploded. In our Special Issue on cancers, “Therapy Development in Renal Cell Carcinoma”, the decision to use therapy as opposed to treatment was intentional. Current multidisciplinary therapies include surgical intervention, radiation therapy, interventional ablative techniques, and systemic therapy utilizing immunotherapy and targeted therapy.
-
Sep 10, 2023 |
biorxiv.org | Shannon Loncar |Matthew Campbell |Robert Gifford |Marco A Quezada-Ramirez
AbstractGene transfer into hematopoietic stem and progenitor cells (HSPCs) involving indiscriminately integrating viral vectors has unpredictable outcomes including potential adverse events such as leukemogenesis, resulting from insertional mutagenesis. Therefore, identifying and characterizing genomic safe harbor (GSH) sites where exogenous genetic information can be integrated safely into adult progenitor and stem cells is critically important for therapeutic gene addition.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →